Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer
全基因组 CRISPR-Cas9 基因敲除筛选发现 GRB7 是 KRAS 突变型结肠癌中 MEK 抑制剂耐药性的驱动因素
期刊:Oncogene
影响因子:7.3
doi:10.1038/s41388-021-02077-w
Yu, Chune; Luo, Dan; Yu, Jing; Zhang, Min; Zheng, Xiaobo; Xu, Guangchao; Wang, Jiaxin; Wang, Huiling; Xu, Yufei; Jiang, Ke; Xu, Jie; Ma, Xuelei; Jing, Jing; Shi, Hubing